Towards Healthcare
Genomic Urine Testing Market Skyrockets USD 319.14 Mn by 2034

Genomic Urine Testing Market Strategic Insights and Key Players

Market insights predict the global genomic urine testing industry will increase from USD 148.23 million in 2024 to USD 319.14 million by 2034, achieving a CAGR of 7.94%. The genomic urine testing market is growing due to its enhanced ability to predict various severe conditions, such as bladder cancer. This testing can predict and avoid diseases in the early stage.

Content

  • Insight Code: 5779
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

With a projected market size of USD 319.14 million by 2034 and a CAGR of 7.94%, the market holds high investment potential.

Key disruptive technologies include next-generation sequencing (NGS), AI-driven genomic interpretation, and point-of-care (POC) testing devices

AI enhances genomic testing by rapidly analyzing large genetic datasets, improving mutation detection accuracy, and enabling predictive analytics.

Asia-Pacific is the fastest-growing region due to aging populations, chronic disease prevalence, government-backed precision medicine programs, and increasing affordability of advanced diagnostics.

Governments play a crucial role, especially through funding genomic research, supporting data infrastructure, and encouraging personalized medicine.
Any Questions